1 Study Coverage
    1.1 Injectable Nanomedicines Product Introduction
    1.2 Market by Type
        1.2.1 Global Injectable Nanomedicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Liposomes
        1.2.3 Micelles
        1.2.4 Nanocrystals
        1.2.5 Polymeric Nanoparticles
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global Injectable Nanomedicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cancer
        1.3.3 Central Nervous System Disease
        1.3.4 Cardiovascular Disease
        1.3.5 Infection Control
        1.3.6 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Injectable Nanomedicines Sales Estimates and Forecasts 2017-2028
    2.2 Global Injectable Nanomedicines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Injectable Nanomedicines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Injectable Nanomedicines Sales by Region
        2.4.1 Global Injectable Nanomedicines Sales by Region (2017-2022)
        2.4.2 Global Sales Injectable Nanomedicines by Region (2023-2028)
    2.5 Global Injectable Nanomedicines Revenue by Region
        2.5.1 Global Injectable Nanomedicines Revenue by Region (2017-2022)
        2.5.2 Global Injectable Nanomedicines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Injectable Nanomedicines Sales by Manufacturers
        3.1.1 Global Top Injectable Nanomedicines Manufacturers by Sales (2017-2022)
        3.1.2 Global Injectable Nanomedicines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Injectable Nanomedicines in 2021
    3.2 Global Injectable Nanomedicines Revenue by Manufacturers
        3.2.1 Global Injectable Nanomedicines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Injectable Nanomedicines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Injectable Nanomedicines Revenue in 2021
    3.3 Global Injectable Nanomedicines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Injectable Nanomedicines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Injectable Nanomedicines Sales by Type
        4.1.1 Global Injectable Nanomedicines Historical Sales by Type (2017-2022)
        4.1.2 Global Injectable Nanomedicines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    4.2 Global Injectable Nanomedicines Revenue by Type
        4.2.1 Global Injectable Nanomedicines Historical Revenue by Type (2017-2022)
        4.2.2 Global Injectable Nanomedicines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    4.3 Global Injectable Nanomedicines Price by Type
        4.3.1 Global Injectable Nanomedicines Price by Type (2017-2022)
        4.3.2 Global Injectable Nanomedicines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Injectable Nanomedicines Sales by Application
        5.1.1 Global Injectable Nanomedicines Historical Sales by Application (2017-2022)
        5.1.2 Global Injectable Nanomedicines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    5.2 Global Injectable Nanomedicines Revenue by Application
        5.2.1 Global Injectable Nanomedicines Historical Revenue by Application (2017-2022)
        5.2.2 Global Injectable Nanomedicines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    5.3 Global Injectable Nanomedicines Price by Application
        5.3.1 Global Injectable Nanomedicines Price by Application (2017-2022)
        5.3.2 Global Injectable Nanomedicines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Injectable Nanomedicines Market Size by Type
        6.1.1 North America Injectable Nanomedicines Sales by Type (2017-2028)
        6.1.2 North America Injectable Nanomedicines Revenue by Type (2017-2028)
    6.2 North America Injectable Nanomedicines Market Size by Application
        6.2.1 North America Injectable Nanomedicines Sales by Application (2017-2028)
        6.2.2 North America Injectable Nanomedicines Revenue by Application (2017-2028)
    6.3 North America Injectable Nanomedicines Market Size by Country
        6.3.1 North America Injectable Nanomedicines Sales by Country (2017-2028)
        6.3.2 North America Injectable Nanomedicines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Injectable Nanomedicines Market Size by Type
        7.1.1 Europe Injectable Nanomedicines Sales by Type (2017-2028)
        7.1.2 Europe Injectable Nanomedicines Revenue by Type (2017-2028)
    7.2 Europe Injectable Nanomedicines Market Size by Application
        7.2.1 Europe Injectable Nanomedicines Sales by Application (2017-2028)
        7.2.2 Europe Injectable Nanomedicines Revenue by Application (2017-2028)
    7.3 Europe Injectable Nanomedicines Market Size by Country
        7.3.1 Europe Injectable Nanomedicines Sales by Country (2017-2028)
        7.3.2 Europe Injectable Nanomedicines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Injectable Nanomedicines Market Size by Type
        8.1.1 Asia Pacific Injectable Nanomedicines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Injectable Nanomedicines Revenue by Type (2017-2028)
    8.2 Asia Pacific Injectable Nanomedicines Market Size by Application
        8.2.1 Asia Pacific Injectable Nanomedicines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Injectable Nanomedicines Revenue by Application (2017-2028)
    8.3 Asia Pacific Injectable Nanomedicines Market Size by Region
        8.3.1 Asia Pacific Injectable Nanomedicines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Injectable Nanomedicines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Injectable Nanomedicines Market Size by Type
        9.1.1 Latin America Injectable Nanomedicines Sales by Type (2017-2028)
        9.1.2 Latin America Injectable Nanomedicines Revenue by Type (2017-2028)
    9.2 Latin America Injectable Nanomedicines Market Size by Application
        9.2.1 Latin America Injectable Nanomedicines Sales by Application (2017-2028)
        9.2.2 Latin America Injectable Nanomedicines Revenue by Application (2017-2028)
    9.3 Latin America Injectable Nanomedicines Market Size by Country
        9.3.1 Latin America Injectable Nanomedicines Sales by Country (2017-2028)
        9.3.2 Latin America Injectable Nanomedicines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Injectable Nanomedicines Market Size by Type
        10.1.1 Middle East and Africa Injectable Nanomedicines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Injectable Nanomedicines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Injectable Nanomedicines Market Size by Application
        10.2.1 Middle East and Africa Injectable Nanomedicines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Injectable Nanomedicines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Injectable Nanomedicines Market Size by Country
        10.3.1 Middle East and Africa Injectable Nanomedicines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Injectable Nanomedicines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 Lupin
        11.2.1 Lupin Corporation Information
        11.2.2 Lupin Overview
        11.2.3 Lupin Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Lupin Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Lupin Recent Developments
    11.3 Pacira Pharmaceuticals
        11.3.1 Pacira Pharmaceuticals Corporation Information
        11.3.2 Pacira Pharmaceuticals Overview
        11.3.3 Pacira Pharmaceuticals Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pacira Pharmaceuticals Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pacira Pharmaceuticals Recent Developments
    11.4 Celgene Pharmaceutical
        11.4.1 Celgene Pharmaceutical Corporation Information
        11.4.2 Celgene Pharmaceutical Overview
        11.4.3 Celgene Pharmaceutical Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Celgene Pharmaceutical Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Celgene Pharmaceutical Recent Developments
    11.5 Amgen
        11.5.1 Amgen Corporation Information
        11.5.2 Amgen Overview
        11.5.3 Amgen Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Amgen Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Amgen Recent Developments
    11.6 Janssen Biotech
        11.6.1 Janssen Biotech Corporation Information
        11.6.2 Janssen Biotech Overview
        11.6.3 Janssen Biotech Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Janssen Biotech Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Janssen Biotech Recent Developments
    11.7 Pfizer
        11.7.1 Pfizer Corporation Information
        11.7.2 Pfizer Overview
        11.7.3 Pfizer Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Pfizer Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Pfizer Recent Developments
    11.8 Hoffmann-La Roche
        11.8.1 Hoffmann-La Roche Corporation Information
        11.8.2 Hoffmann-La Roche Overview
        11.8.3 Hoffmann-La Roche Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Hoffmann-La Roche Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Hoffmann-La Roche Recent Developments
    11.9 Teva Pharmaceutical Industries
        11.9.1 Teva Pharmaceutical Industries Corporation Information
        11.9.2 Teva Pharmaceutical Industries Overview
        11.9.3 Teva Pharmaceutical Industries Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Teva Pharmaceutical Industries Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Teva Pharmaceutical Industries Recent Developments
    11.10 Bausch & Lomb
        11.10.1 Bausch & Lomb Corporation Information
        11.10.2 Bausch & Lomb Overview
        11.10.3 Bausch & Lomb Injectable Nanomedicines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Bausch & Lomb Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Bausch & Lomb Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Injectable Nanomedicines Industry Chain Analysis
    12.2 Injectable Nanomedicines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Injectable Nanomedicines Production Mode & Process
    12.4 Injectable Nanomedicines Sales and Marketing
        12.4.1 Injectable Nanomedicines Sales Channels
        12.4.2 Injectable Nanomedicines Distributors
    12.5 Injectable Nanomedicines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Injectable Nanomedicines Industry Trends
    13.2 Injectable Nanomedicines Market Drivers
    13.3 Injectable Nanomedicines Market Challenges
    13.4 Injectable Nanomedicines Market Restraints
14 Key Findings in The Global Injectable Nanomedicines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Injectable Nanomedicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Liposomes
    Table 3. Major Manufacturers of Micelles
    Table 4. Major Manufacturers of Nanocrystals
    Table 5. Major Manufacturers of Polymeric Nanoparticles
    Table 6. Major Manufacturers of Other
    Table 7. Global Injectable Nanomedicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Injectable Nanomedicines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Injectable Nanomedicines Sales by Region (2017-2022) & (MT)
    Table 10. Global Injectable Nanomedicines Sales Market Share by Region (2017-2022)
    Table 11. Global Injectable Nanomedicines Sales by Region (2023-2028) & (MT)
    Table 12. Global Injectable Nanomedicines Sales Market Share by Region (2023-2028)
    Table 13. Global Injectable Nanomedicines Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Injectable Nanomedicines Revenue Market Share by Region (2017-2022)
    Table 15. Global Injectable Nanomedicines Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Injectable Nanomedicines Revenue Market Share by Region (2023-2028)
    Table 17. Global Injectable Nanomedicines Sales by Manufacturers (2017-2022) & (MT)
    Table 18. Global Injectable Nanomedicines Sales Share by Manufacturers (2017-2022)
    Table 19. Global Injectable Nanomedicines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Injectable Nanomedicines Revenue Share by Manufacturers (2017-2022)
    Table 21. Injectable Nanomedicines Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 22. Global Injectable Nanomedicines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Injectable Nanomedicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Nanomedicines as of 2021)
    Table 24. Injectable Nanomedicines Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Injectable Nanomedicines Product Offered
    Table 26. Date of Manufacturers Enter into Injectable Nanomedicines Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 29. Global Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 30. Global Injectable Nanomedicines Sales Share by Type (2017-2022)
    Table 31. Global Injectable Nanomedicines Sales Share by Type (2023-2028)
    Table 32. Global Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Injectable Nanomedicines Revenue Share by Type (2017-2022)
    Table 35. Global Injectable Nanomedicines Revenue Share by Type (2023-2028)
    Table 36. Injectable Nanomedicines Price by Type (2017-2022) & (USD/Kg)
    Table 37. Global Injectable Nanomedicines Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 38. Global Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 39. Global Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 40. Global Injectable Nanomedicines Sales Share by Application (2017-2022)
    Table 41. Global Injectable Nanomedicines Sales Share by Application (2023-2028)
    Table 42. Global Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Injectable Nanomedicines Revenue Share by Application (2017-2022)
    Table 45. Global Injectable Nanomedicines Revenue Share by Application (2023-2028)
    Table 46. Injectable Nanomedicines Price by Application (2017-2022) & (USD/Kg)
    Table 47. Global Injectable Nanomedicines Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 48. North America Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 49. North America Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 50. North America Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 53. North America Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 54. North America Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Injectable Nanomedicines Sales by Country (2017-2022) & (MT)
    Table 57. North America Injectable Nanomedicines Sales by Country (2023-2028) & (MT)
    Table 58. North America Injectable Nanomedicines Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Injectable Nanomedicines Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 61. Europe Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 62. Europe Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 65. Europe Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 66. Europe Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Injectable Nanomedicines Sales by Country (2017-2022) & (MT)
    Table 69. Europe Injectable Nanomedicines Sales by Country (2023-2028) & (MT)
    Table 70. Europe Injectable Nanomedicines Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Injectable Nanomedicines Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 73. Asia Pacific Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 74. Asia Pacific Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 77. Asia Pacific Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 78. Asia Pacific Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Injectable Nanomedicines Sales by Region (2017-2022) & (MT)
    Table 81. Asia Pacific Injectable Nanomedicines Sales by Region (2023-2028) & (MT)
    Table 82. Asia Pacific Injectable Nanomedicines Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Injectable Nanomedicines Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 85. Latin America Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 86. Latin America Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 89. Latin America Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 90. Latin America Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Injectable Nanomedicines Sales by Country (2017-2022) & (MT)
    Table 93. Latin America Injectable Nanomedicines Sales by Country (2023-2028) & (MT)
    Table 94. Latin America Injectable Nanomedicines Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Injectable Nanomedicines Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Injectable Nanomedicines Sales by Type (2017-2022) & (MT)
    Table 97. Middle East and Africa Injectable Nanomedicines Sales by Type (2023-2028) & (MT)
    Table 98. Middle East and Africa Injectable Nanomedicines Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Injectable Nanomedicines Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Injectable Nanomedicines Sales by Application (2017-2022) & (MT)
    Table 101. Middle East and Africa Injectable Nanomedicines Sales by Application (2023-2028) & (MT)
    Table 102. Middle East and Africa Injectable Nanomedicines Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Injectable Nanomedicines Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Injectable Nanomedicines Sales by Country (2017-2022) & (MT)
    Table 105. Middle East and Africa Injectable Nanomedicines Sales by Country (2023-2028) & (MT)
    Table 106. Middle East and Africa Injectable Nanomedicines Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Injectable Nanomedicines Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Merck Corporation Information
    Table 109. Merck Description and Major Businesses
    Table 110. Merck Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 111. Merck Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Merck Recent Developments
    Table 113. Lupin Corporation Information
    Table 114. Lupin Description and Major Businesses
    Table 115. Lupin Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 116. Lupin Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Lupin Recent Developments
    Table 118. Pacira Pharmaceuticals Corporation Information
    Table 119. Pacira Pharmaceuticals Description and Major Businesses
    Table 120. Pacira Pharmaceuticals Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 121. Pacira Pharmaceuticals Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Pacira Pharmaceuticals Recent Developments
    Table 123. Celgene Pharmaceutical Corporation Information
    Table 124. Celgene Pharmaceutical Description and Major Businesses
    Table 125. Celgene Pharmaceutical Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 126. Celgene Pharmaceutical Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Celgene Pharmaceutical Recent Developments
    Table 128. Amgen Corporation Information
    Table 129. Amgen Description and Major Businesses
    Table 130. Amgen Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 131. Amgen Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Amgen Recent Developments
    Table 133. Janssen Biotech Corporation Information
    Table 134. Janssen Biotech Description and Major Businesses
    Table 135. Janssen Biotech Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 136. Janssen Biotech Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Janssen Biotech Recent Developments
    Table 138. Pfizer Corporation Information
    Table 139. Pfizer Description and Major Businesses
    Table 140. Pfizer Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 141. Pfizer Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Pfizer Recent Developments
    Table 143. Hoffmann-La Roche Corporation Information
    Table 144. Hoffmann-La Roche Description and Major Businesses
    Table 145. Hoffmann-La Roche Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 146. Hoffmann-La Roche Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Hoffmann-La Roche Recent Developments
    Table 148. Teva Pharmaceutical Industries Corporation Information
    Table 149. Teva Pharmaceutical Industries Description and Major Businesses
    Table 150. Teva Pharmaceutical Industries Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 151. Teva Pharmaceutical Industries Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Teva Pharmaceutical Industries Recent Developments
    Table 153. Bausch & Lomb Corporation Information
    Table 154. Bausch & Lomb Description and Major Businesses
    Table 155. Bausch & Lomb Injectable Nanomedicines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 156. Bausch & Lomb Injectable Nanomedicines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Bausch & Lomb Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Injectable Nanomedicines Distributors List
    Table 161. Injectable Nanomedicines Customers List
    Table 162. Injectable Nanomedicines Market Trends
    Table 163. Injectable Nanomedicines Market Drivers
    Table 164. Injectable Nanomedicines Market Challenges
    Table 165. Injectable Nanomedicines Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Injectable Nanomedicines Product Picture
    Figure 3. Global Injectable Nanomedicines Market Share by Type in 2021 & 2028
    Figure 3. Liposomes Product Picture
    Figure 4. Micelles Product Picture
    Figure 5. Nanocrystals Product Picture
    Figure 6. Polymeric Nanoparticles Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Injectable Nanomedicines Market Share by Application in 2021 & 2028
    Figure 9. Cancer
    Figure 10. Central Nervous System Disease
    Figure 11. Cardiovascular Disease
    Figure 12. Infection Control
    Figure 13. Other
    Figure 14. Injectable Nanomedicines Report Years Considered
    Figure 15. Global Injectable Nanomedicines Sales 2017-2028 (MT)
    Figure 16. Global Injectable Nanomedicines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Injectable Nanomedicines Revenue 2017-2028 (US$ Million)
    Figure 18. Global Injectable Nanomedicines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Injectable Nanomedicines Sales Market Share by Region (2017-2022)
    Figure 20. Global Injectable Nanomedicines Sales Market Share by Region (2023-2028)
    Figure 21. North America Injectable Nanomedicines Sales YoY (2017-2028) & (MT)
    Figure 22. North America Injectable Nanomedicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Injectable Nanomedicines Sales YoY (2017-2028) & (MT)
    Figure 24. Europe Injectable Nanomedicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Injectable Nanomedicines Sales YoY (2017-2028) & (MT)
    Figure 26. Asia-Pacific Injectable Nanomedicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Injectable Nanomedicines Sales YoY (2017-2028) & (MT)
    Figure 28. Latin America Injectable Nanomedicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Injectable Nanomedicines Sales YoY (2017-2028) & (MT)
    Figure 30. Middle East & Africa Injectable Nanomedicines Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Injectable Nanomedicines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Injectable Nanomedicines in the World: Market Share by Injectable Nanomedicines Revenue in 2021
    Figure 33. Global Injectable Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 35. Global Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 36. Global Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 37. Global Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 38. North America Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 39. North America Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 40. North America Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 41. North America Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 42. North America Injectable Nanomedicines Sales Share by Country (2017-2028)
    Figure 43. North America Injectable Nanomedicines Revenue Share by Country (2017-2028)
    Figure 44. U.S. Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 47. Europe Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 49. Europe Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Injectable Nanomedicines Sales Share by Country (2017-2028)
    Figure 51. Europe Injectable Nanomedicines Revenue Share by Country (2017-2028)
    Figure 52. Germany Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 53. France Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Injectable Nanomedicines Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Injectable Nanomedicines Revenue Share by Region (2017-2028)
    Figure 63. China Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 66. India Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Injectable Nanomedicines Sales Share by Country (2017-2028)
    Figure 78. Latin America Injectable Nanomedicines Revenue Share by Country (2017-2028)
    Figure 79. Mexico Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Injectable Nanomedicines Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Injectable Nanomedicines Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Injectable Nanomedicines Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Injectable Nanomedicines Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Injectable Nanomedicines Revenue Share by Country (2017-2028)
    Figure 88. Turkey Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Injectable Nanomedicines Revenue (2017-2028) & (US$ Million)
    Figure 91. Injectable Nanomedicines Value Chain
    Figure 92. Injectable Nanomedicines Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed